Cargando…

Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma

Tyrosine is an essential ketogenic and glycogenic amino acid for the human body, which means that tyrosine is not only involved in protein metabolism, but also participates in the metabolism of lipids and carbohydrates. The liver is an important place for metabolism of lipids, carbohydrates, and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiyan, Qiao, Yaya, Sun, Huanran, Chang, Hongkai, Zhao, Huifang, Zhang, Shuai, Shan, Changliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869743/ https://www.ncbi.nlm.nih.gov/pubmed/35203444 http://dx.doi.org/10.3390/biomedicines10020234

Ejemplares similares

Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022)

The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology
por: Wang, Jiyan, et al.
Publicado: (2022)

PRIM2 Promotes Cell Cycle and Tumor Progression in p53-Mutant Lung Cancer
por: Wang, Taoyuan, et al.
Publicado: (2022)

Interruption of bile acid enterohepatic circulation inhibits glycogen synthesis and promotes hepatocellular carcinoma progression
por: Wang, Jiyan, et al.
Publicado: (2023)

FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1
por: Wang, Jiyan, et al.
Publicado: (2022)

PIKE-A Modulates Mitochondrial Metabolism through Increasing SDHA Expression Mediated by STAT3/FTO Axis
por: Sun, Mingming, et al.
Publicado: (2022)

The Multiple Roles of Glucose-6-Phosphate Dehydrogenase in Tumorigenesis and Cancer Chemoresistance
por: Song, Jiaqi, et al.
Publicado: (2022)

Valproic acid Suppresses Breast Cancer Cell Growth Through Triggering Pyruvate Kinase M2 Isoform Mediated Warburg Effect
por: Li, Zhen, et al.
Publicado: (2021)

PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism
por: Sun, Mingming, et al.
Publicado: (2023)

SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase
por: Xu, Feng-li, et al.
Publicado: (2023)

Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism
por: Zhong, Xuemin, et al.
Publicado: (2022)

The dysfunctional Wnt pathway down-regulates MLH1/SET expression and promotes microsatellite instability and immunotherapy response in colorectal cancer
por: Wang, Jiyan, et al.
Publicado: (2023)

Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism
por: Maekawa, Motoko, et al.
Publicado: (2015)

Erratum: Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism
por: Maekawa, Motoko, et al.
Publicado: (2016)

Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma
por: Wang, Dongyao, et al.
Publicado: (2022)

PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1
por: Xie, Fei, et al.
Publicado: (2023)

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
por: Ma, Xiaowu, et al.
Publicado: (2022)

Reduced Expression of Very-Long-Chain Acyl-CoA Synthetases SLC27A4 and SLC27A6 in the Glioblastoma Tumor Compared to the Peritumoral Area
por: Korbecki, Jan, et al.
Publicado: (2023)

Copper Chaperone for Superoxide Dismutase Promotes Breast Cancer Cell Proliferation and Migration via ROS-Mediated MAPK/ERK Signaling
por: Li, Yanping, et al.
Publicado: (2019)

Up-regulation of SLC27A2 suppresses the proliferation and invasion of renal cancer by down-regulating CDK3-mediated EMT
por: Xu, Ning, et al.
Publicado: (2022)

Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins
por: Niu, Yongjie, et al.
Publicado: (2020)

LncRNA HOXD-AS1 promotes the metastasis of human hepatocellular carcinoma via modulating miR-326/SLC27A4
por: Ji, Wenbin, et al.
Publicado: (2020)

USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis
por: Dong, Ling, et al.
Publicado: (2018)

Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle
por: Nojiri, Shunsuke, et al.
Publicado: (2014)

Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays
por: Zhang, Fan, et al.
Publicado: (2021)

Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases
por: Zhu, Ying, et al.
Publicado: (2021)

UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development
por: Zhang, Ren-Yu, et al.
Publicado: (2021)

Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response
por: Yan, Jia, et al.
Publicado: (2023)

New Insight on Solute Carrier Family 27 Member 6 (SLC27A6) in Tumoral and Non-Tumoral Breast Cells
por: Yen, Meng-Chi, et al.
Publicado: (2019)

Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation
por: Yuan, Peng, et al.
Publicado: (2021)

Systemic characterization of the SLC family genes reveals SLC26A6 as a novel oncogene in hepatocellular carcinoma
por: Cao, Jianzhong, et al.
Publicado: (2021)

Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells
por: Yen, Meng-Chi, et al.
Publicado: (2018)

ORY-1001 Suppresses Cell Growth and Induces Apoptosis in Lung Cancer Through Triggering HK2 Mediated Warburg Effect
por: Lu, Zhaoliang, et al.
Publicado: (2018)

Lipids link immune suppression to effective immunotherapy in steatotic hepatocellular carcinoma
por: Li, Bing, et al.
Publicado: (2023)

Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity
por: Ye, Wen, et al.
Publicado: (2017)

Immunological effect of tyrosine kinase inhibitors on the tumor immune environment in non-small cell lung cancer
por: Jiang, Li, et al.
Publicado: (2022)

c-Src kinase is involved in the tyrosine phosphorylation and activity of SLC11A1 in differentiating macrophages
por: Xu, Yong Zhong, et al.
Publicado: (2018)

Zip4 (Slc39a4) Expression is Activated in Hepatocellular Carcinomas and Functions to Repress Apoptosis, Enhance Cell Cycle and Increase Migration
por: Weaver, Benjamin P., et al.
Publicado: (2010)

Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells
por: Blain, Stacy W.
Publicado: (2018)

GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway
por: Wang, Hongxv, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3m5n0cld2g0ncdssgul2e7a0mi